2014 FDA Drug Approvals

36 DRUGS

10 COMPANIESDRUGS

2014 YEAR IN REVIEW

FDADRUG APPROVALS

Novel Drugs Approved in 2014

APPROVED

Type 2 Diabetes

Source: FDA.GOV

FARXIGA 1

Non­24­Hour Sleep­Wake Disorder

Source: FDA.GOV

HETLIOZ 2

Morquio A Syndrome

Source: FDA.GOV

VIMIZIM 3

Neurogenic Orthostatic Hypotension(NOH)

Source: FDA.GOV

NORTHERA 4

Complications of Leptin Deficiency

Source: FDA.GOV

MYALEPT 5

Positron Emission Tomography (PET)Imaging of the Brain

Source: FDA.GOV

NEURACEQ 6

Leishmaniasis

Source: FDA.GOV

IMPAVIDO 7

Moderate to Severe Plaque Psoriasis

Source: FDA.GOV

OTEZLA 8

Type 2 Diabetes

Source: FDA.GOV

TANZEUM 9

Advanced Stomach Cancer orGastroesophageal JunctionAdenocarcinoma

Source: FDA.GOV

CYRAMZA 10

Multicentric Castleman’s Disease (MCD)

Source: FDA.GOV

SYLVANT 11

Anaplastic Lymphoma Kinase­Positive(ALK+) Metastatic Non­Small Cell LungCancer (NSCLC)

Source: FDA.GOV

ZYKADIA 12

Reduce Risk of Heart Attacks and Stroke inHigh­Risk Patients

Source: FDA.GOV

ZONTIVITY 13

Severe Ulcerative Colitis and AdultPatients with Moderate to Severe Crohn‘sDisease

Source: FDA.GOV

ENTYVIO 14

Acute Bacterial Skin and Skin StructureInfections

Source: FDA.GOV

DALVANCE 15

Toenail Fungus

Source: FDA.GOV

JUBLIA 16

Acute Bacterial Skin and Skin StructureInfections

Source: FDA.GOV

SIVEXTRO 17

Peripheral T­Cell Lymphoma (PTCL)

Source: FDA.GOV

BELEODAQ 18

Toenail Fungus

Source: FDA.GOV

KERYDIN 19

Chronic Lymphocytic Leukemia (CLL)Follicular B­cell non­Hodgkin Lymphoma(FL)Small Lymphocytic Lymphoma (SLL)

Source: FDA.GOV

ZYDELIG 20

Chronic Obstructive Pulmonary Disease(COPD)

Source: FDA.GOV

STRIVERDIRESPIMAT

21

Type 2 Diabetes

Source: FDA.GOV

JARDIANCE 22

Type 2 Diabetes

Source: FDA.GOV

ORBACTIV 23

Insomnia

Source: FDA.GOV

BELSOMRA 24

Relapsing Forms of Multiple Sclerosis (MS)

Source: FDA.GOV

PLEGRIDY 25

Gaucher Disease Type 1

Source: FDA.GOV

CERDELGA 26

Melanoma

Source: FDA.GOV

KEYTRUDA 27

Opioid­Induced Constipation (OIC) in AdultPatients with Chronic Non‑Cancer Pain

Source: FDA.GOV

MOVANTIK 28

Type 2 Diabetes

Source: FDA.GOV

TRULICITY 29

Type 2 Diabetes

Source: FDA.GOV

LUMASON 30

Nausea and Vomiting in PatientsUndergoing Cancer Chemotherapy

Source: FDA.GOV

AKYNZEO 31

Chronic Hepatitis C

Source: FDA.GOV

HARVONI 32

Idiopathic Pulmonary Fibrosis (IPF)

Source: FDA.GOV

ESBRIET 33

Idiopathic Pulmonary Fibrosis (IPF)

Source: FDA.GOV

OFEV 34

Acute Lymphoblastic Leukemia

Source: FDA.GOV

BLINCYTO 35

Otitis Externa (Swimmer's Ear)

Source: FDA.GOV

XTORO 36

Advanced Ovarian Cancer

Source: FDA.GOV

LYNPARZA 37

Chronic Genotype 1 Hepatitis C

Source: FDA.GOV

VIEKIRA PAK 38

COMPLICATED URINARY TRACT ANDCOMPLICATED INTRA­ABDOMINALINFECTIONS

Source: FDA.GOV

ZERBAXA 39

Acute Uncomplicated Influenza

Source: FDA.GOV

RAPIVAB 40

Advanced Melanoma

Source: FDA.GOV

OPDIVO 41

Chronic Weight Management

Source: FDA.GOV

SAXENDA 42

Chronic Lymphocytic Leukemia

Source: FDA.GOV

IMBRUVICA 43

Type 2 Diabetes

Source: FDA.GOV

INVOKAMET 44

Inflammatory Lesions, Bumps andPimples, of Rosacea

Source: FDA.GOV

SOOLANTRA 45

36 DRUGS

10 COMPANIES

DRUGS

CREATED BY: